UNITI results 20231201

UNITI results

UNITI project finished in September 2023. It’s overall aim was to deliver a predictive computational model based on existing and longitudinal data attempting to address the question which treatment approach is optimal for a specific patient based on specific parameters. Clinical, epidemiological, medical, genetic and audiological data, including signals reflecting ear-brain communication, were analysed from existing databases. Predictive factors for different patient groups were extracted and their prognostic relevance were tested in a randomized controlled trial (RCT) in which different groups of patients underwent a combination of therapies targeting the auditory and central nervous systems.

Click here to learn more about the UNITI results.

 

 

The UNITI consortium is glad and thankful to report that on December 15, 2020, Ronny Hannemann (right) of WSA/Sivantos (also member of the UNITI Advisory Board) handed over a first delivery of 220 (of 400) Signia Pure 312 X hearing aids to UNITI Project Coordinator Winfried Schlee (left) and ENT colleagues Veronika Vielsmeier and Steven Marcrum at the Regensburg University Hospital, UKR.

For the UNITI clinical trial, foreseen to start in early 2021, hearing aid provision to study participants with hearing aid indication will be one treatment arm. Now, the devices will be set-up by head audiologist Steven Marcrum, and also sent to the other four clinical centres

Social Media

Logo Facebook Logo Twitter Logo Instagram Logo LinkedIn Logo Researchgate

Key Facts

Data and analysis scripts of the UNITI-RCT results are currently available upon request (stefan.schoisswohl@klinik.uni-regensburg.de).

Upcoming Events

No events found